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Cell metabolism is adaptive to extrinsic demands;
however, the intrinsic metabolic demands that drive
the induced pluripotent stem cell (iPSC) program
remain unclear. Although glycolysis increases
throughout the reprogramming process, we show
that the estrogen-related nuclear receptors (ERRa
and ERRg) and their partnered co-factors PGC-1a
and PGC-1b are transiently induced at an early
stage, resulting in a burst of oxidative phosphoryla-
tion (OXPHOS) activity. Upregulation of ERRa or
ERRg is required for the OXPHOS burst in both hu-
man and mouse cells, respectively, as well as iPSC
generation itself. Failure to induce this metabolic
switch collapses the reprogramming process.
Furthermore, we identify a rare pool of Sca1/
CD34 sortable cells that is highly enriched in bona
fide reprogramming progenitors. Transcriptional
profiling confirmed that these progenitors are
ERRg and PGC-1b positive and have undergone
extensive metabolic reprogramming. These studies
characterize a previously unrecognized, ERR-
dependent metabolic gate prior to establishment of
induced pluripotency.
INTRODUCTION
An understanding of the molecular mechanisms that influence
the generation, maintenance, and differentiation of human
pluripotent stem cells is key to advancing their use in a therapeu-
tic setting. Whereas the transcriptional and epigenetic dynamics
have been extensively documented (Buganim et al., 2012;
O’Malley et al., 2013; Polo et al., 2012; Theunissen and Jaenisch,
2014), temporal changes inmetabolic states during the inductionof pluripotency remain largely unknown. Distinct from somatic
cells, pluripotent stem cells have unique metabolic pathways
(Zhang et al., 2012), which influence their cellular behavior and
epigenetic status (Lu and Thompson, 2012; Shyh-Chang et al.,
2013a, 2013b). Indeed, factors involved in metabolic functions
such as mitochondrial proteins are among the first to be upregu-
lated in cells undergoing reprogramming (Hansson et al., 2012).
Therefore, delineating the molecular mechanisms governing the
dynamic regulation of cellular metabolism is crucial to under-
standing the connections between metabolic and epigenetic
reprogramming.
Nuclear receptors (NRs) are pleiotropic regulators of organ
physiology controlling broad aspects of glucose and fatty acid
metabolism and overall energy homeostasis (Mangelsdorf
et al., 1995; Yang et al., 2006). While orphan receptors such
as the estrogen-related receptors (ERRs) are ligand indepen-
dent, they nonetheless are capable of directing dramatic
changes in both glycolytic and oxidative metabolism in tissues
with high energy demands (Giguere et al., 1988). ERRs switch
between various oxidative states by associating preferentially
with their co-activators PGC-1a/b (Dufour et al., 2011; Schreiber
et al., 2003). The ERR family member ERRb (also known as
Esrrb) is glycolytic in the absence of PGC-1a and plays a key
role in establishing pluripotency (Buganim et al., 2012; Feng
et al., 2009; Festuccia et al., 2012; Martello et al., 2012). In
contrast, ERRa and ERRg, which are expressed in oxidative tis-
sues such as skeletal muscle and heart (Narkar et al., 2011),
have not previously been linked to induced pluripotent stem
cell (iPSC) generation. In this study, we identify transient upre-
gulation of ERRa and ERRg in the early stages of reprogram-
ming that induce a unique energetic state. Furthermore, we
show that the transient OXPHOS burst and increased glycolysis
initiated by this metabolic switch are essential for epigenetic re-
programming. Mechanistically, ERRa and ERRg are enriched in
bona fide reprogramming progenitors and induce widespread
changes in metabolic gene networks. Our results suggest that
an ERR-mediated metabolic transition is required for induced
pluripotency.Cell Stem Cell 16, 547–555, May 7, 2015 ª2015 Elsevier Inc. 547
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Figure 1. ERRa/g and PGC1a/b Are Required for Induced Pluripotency in Both Mouse and Human Cells
(A) MEFs undergoing retroviral reprogramming with OSKM were transduced with control, ERRa, ERRg, PGC-1a, or PGC-1b shRNA. Depletion of ERRa/g and
PGC-1a/b significantly reduce reprogramming efficiency (n = 3, error bars show SD).
(B–F) ERRglox/lox and ERRglox/loxCreERTMEFs infected with a doxycycline-inducible OSKM lentivirus were treated with 4-OHT 3 days after OSKM induction. This
is a bright-field image showing that ERRg depletion reduced the clusters of early reprogramming cells (B), significantly reduced AP colonies (C and D), and
reduced Nanog-positive colonies (E and F) (n = 3, *p < 0.01, error bars show SD).
(G) ERRa and PGC-1a/b are required for reprogramming of human lung fibroblast IMR90 (n = 3, *p < 0.01, error bars show SD).
(H and I) qPCR results show that depletion of p53 leads to increased expression of human ERRa during reprogramming of IMR90 cells (n = 3, *p < 0.01, error bars
show SEM).
(J) Nanog staining of retroviral OSKM-infected MEFs with p53 (left), or p53 and ERRg (right) shRNA vectors, demonstrating that loss of ERRg results in complete
collapse of reprogramming even with p53 depletion.RESULTS
ERRa/g Are Essential for Somatic Cell Reprogramming
Temporal gene expression studies in mouse embryonic fibro-
blasts (MEFs) after reprogramming with Oct4, Sox2, Klf4, and
cMyc (OSKM) or OSK revealed transient increases in the expres-
sion of ERRg, PGC-1a, PGC-1b, and to a lesser extent ERRa,
3 days after infection (Figures S1A–S1D; data not shown).
Furthermore, depletion of ERRg, PGC-1a, or PGC-1b by shRNA
knockdown coincident with OSKM induction significantly
reduced reprogramming efficiency in MEFs (Figure 1A), whereas
ERRg depletion later in reprogramming had little effect (Fig-
ure S1E). To further explore the timing of gene induction in early548 Cell Stem Cell 16, 547–555, May 7, 2015 ª2015 Elsevier Inc.reprogramming, OSKM expression was induced in MEFs iso-
lated from ERRglox/lox and ERRglox/loxCreERT mice via doxycy-
cline-inducible lentiviruses (Wei et al., 2009). While tamoxifen-
treated ERRglox/lox MEFs (ERRg control cells) exhibited multiple
foci of reprogramming cells 5 days after doxycycline-induced
OSKMexpression, ERRglox/loxCreERTMEFs treatedwith tamox-
ifen at day 3 (ERRg iKO cells) displayed fibroblast-like
morphology (Figure 1B). Consistent with a failure of the ERRg
iKO cells to reprogram, few alkaline phosphatase (AP) or
Nanog-positive colonies were observed after 3 weeks of
OSKM infection, whereas control cells showed normal reprog-
ramming efficiency (Figures 1C–1F). As depletion of ERRg or
ERRa in reprogramming cells leads to a reduction in cell
proliferation (Figure S1F), we also compared the reprogramming
efficiencies of immortalized MEFs generated from ERRg
knockout (ERRg/) or WT (ERRg+/+) mouse embryos. No
Nanog-positive cells were detected in ERRg/ cells after
OSKM infection (Figure S1G). Together, these findings suggest
that the induction of ERRg early in reprogramming is essential
for iPSC generation from MEFs.
Similar gene expression patterns were observed during the re-
programming of human lung fibroblast IMR90 cells and adipose-
derived stem cells (ADSCs), with the distinction that ERRa, rather
than ERRg, was upregulated (Figures S1H–S1J). Parallel shRNA
knockdown studies in the human IMR90 cells revealed a
strong dependence on ERRa expression, alongside PGC-1a
and PGC-1b expression, whereas depletion of ERRg was
partially tolerated (40% reduction in Nanog+ colonies; Fig-
ure 1G), further indicating that ERRa rather than ERRg is required
for iPSC generation in human fibroblasts. Furthermore, knock-
down of p53, previously shown to increase iPSC generation
(Kawamura et al., 2009), resulted in the hyperinduction of
ERRa and Nanog during IMR90 cell reprogramming (Figures
1H and 1I). Notably, the coincident knockdown of ERRg and
p53 essentially blocked iPSC generation in MEFs (Figure 1J),
indicating that the ERR signaling pathway is epistatic to p53-
induced senescence in iPSC reprogramming.
To decipher the molecular mechanisms driving ERR/PGC-1
induction, IMR90 cells were infected with each of the four factors
individually. Distinctive expression patterns for ERRa, PGC-1a,
and PGC1-1b were observed 5 days after infection. Klf4,
c-Myc, and Sox2 were each able to efficiently induce ERRa,
Oct3/4 and Klf4 both induced the expression of PGC-1a,
whereas c-Myc efficiently induced PGC-1b expression (Figures
S1K–S1M). These patterns of gene induction correlate well
with previous ChIP-seq data (Chen et al., 2008) and indicate
that all four reprogramming factors contribute in complementary
ways to produce the operational ERRa transcriptional complex
at day 5 (Figure S1N).
ERRs Direct a Transient Hyperenergetic State Required
for Reprogramming
The increased expression of ERRs and their co-activators led us
to explore whether acutely altered energy flux in the mitochon-
dria may be fueling reprogramming. MEFs from the reprogram-
ming factor doxycycline-inducible mouse (Carey et al., 2010)
reached an OXPHOS peak around days 2–4 after induction (Fig-
ure 2A). Importantly, the maximal OXPHOS capacity was also
significantly increased in early reprogramming MEFs (Figures
2B and S2A). A similar bioenergetics time course recorded on
days 3 to 10 after OSKM infection in human IMR90 cells revealed
a transient increase in mitochondrial OXPHOS that peaked
5 days after infection (2.5- to 5.0-fold increase in oxygen con-
sumption rates [OCRs]) accompanied by a sustained increase
in glycolysis (2.5- to 3.5-fold increase in the extracellular acidifi-
cation rates [ECARs]) (Figures S2B and S2C). Corresponding
with the increased expression of energy regulators, the levels
of both nicotinamide adenine dinucleotide (NADH) and cellular
ATP were increased in IMR90 cells 5 days after infection,
whereas the NAD+/NADH ratio decreased (Figures S2D–S2F).
Together, these results indicate that early reprogramming cells
are in a hyperenergetic state. Closer examination of IMR90 cellsrevealed remarkably coincident temporal expression patterns of
ERRa, PGC-1a, and PGC-1b during the early stages of reprog-
ramming that are consistent with the known role of PCG1a/b
as an ERR cofactor (days 3 to 8; Figure 2C). ERRs and PGC-1s
directly regulate an extensive network of genes controlling
energy homeostasis including proteins involved in fatty acid
oxidation, the TCA cycle, and OXPHOS (Alaynick et al., 2007;
Dufour et al., 2007). Therefore, we examined the temporal
expression pattern of various known regulators of cellular energy
homeostasis during the reprogramming of IMR90 cells. Remark-
ably, multiple key players in energy metabolism, including ATP
synthase in mitochondria (ATP5G1), succinate dehydrogenase
(SDHB), isocitrate dehydrogenase (IDH3A), and NADH dehydro-
genase (NDUFA2), reach peak expression at day 5 (Figures 2D
and S2G). In addition, the induction of superoxide dismutase 2
(SOD2), NADPH oxidase 4 (NOX4), and catalase (CAT) by
OSKM infection (Figure S2H) indicates that the antioxidant pro-
gram is being triggered coordinately with the ERRa-PGC-1
surge.
Pluripotent stem cells are known to mainly rely on glycolysis
to produce energy (Folmes et al., 2012; Shyh-Chang et al.,
2013a; Zhang et al., 2012). Previous studies have focused on
the changes in glycolytic activity during reprogramming, as
elevated glycolysis is linked to a faster cell cycle and iPSC
generation (Folmes et al., 2011; Panopoulos et al., 2012; Shyh-
Chang et al., 2013b). However, our findings suggest that iPSC
precursors undergo a transient increase in oxidative phosphory-
lation (OXPHOS) activity. The dynamics of ECAR support
previous work showing that the glycolytic activity of the cells is
gradually enhanced and maintained during reprogramming to a
level similar to iPSCs (Figures 2A and S2C). In contrast, the
transient burst of OXPHOS during reprogramming of both
human and mouse cells has not been previously documented
(Figures 2A, 2B, and S2B). This led us to investigate the poten-
tial influence of the ERRa/g surge on cell plasticity during
reprogramming.
To examine a potential causal relationship between ERR
expression and the induction of the hyperenergetic state, we
compared the metabolic activities of partially reprogrammed
cells before and after targeted shRNA knockdowns. Notably,
the increase in OXPHOS and glycolysis was completely abro-
gated in cells depleted of ERRs (ERRa in IMR90 cells at day 5
and ERRg in MEFs at day 3; Figures 2E and 2F). Furthermore,
the mitochondrial inhibitor Rotenone significantly reduced
iPSC generation, though only when treatment was coincident
with the observed hyperenergetic state, consistent with the
OXPHOS burst being necessary for reprogramming (Figure 2G).
Additionally, overexpression of ERRg in MEFs 1 day after induc-
tion of OSKM increases reprogramming efficiency 1.8-fold
(Figure S2I). Together, these data indicate that ERRa and
ERRg regulate iPSC generation through the induction of a tran-
sient enhanced metabolic state that is required for somatic cell
reprogramming.
Bona Fide iPSC Progenitors Are Enriched for ERRg
Expression
Under standard conditions, only a small percentage of cells are
successfully reprogrammed into iPSCs (Takahashi and Yama-
naka, 2006; Yu et al., 2007). Given our observation of ametabolicCell Stem Cell 16, 547–555, May 7, 2015 ª2015 Elsevier Inc. 549
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Figure 2. ERRa/g Induces a Metabolic Transition in Early Reprogramming, which Is Essential to Induced Pluripotency
(A) Time course of OCR and ECARs in Dox-induced reprogramming MEFs, isolated from the single gene transgenic mouse, revealed that the reprogramming
population experiences an early OXPHOS burst (n = 6, error bars show SD).
(B) Mitostress test of early reprogramming MEFs in (A) shows increased basal OCR and maximal OXPHOS capacity (n = 6, error bars show SD).
(C) Relative gene expression of ERRa, co-activators PGC-1a and PGC-1b, and Nanog after retroviral OSKM infection of IMR90 cells, measured by qPCR,
suggests that the expression pattern of ERRs and their co-factors coincide with the metabolic switch in early reprogramming (n = 3, *p < 0.01, error bars
show SEM).
(D) Temporal expression of metabolic genes during retroviral OSKM-induced IMR90 reprogramming.
(E) OCR and ECAR measurements of control and ERRa knockdown retroviral reprogramming IMR90 cells demonstrate that ERRa is required for the early
OXPHOS burst in human cells (n = 6, error bars show SD).
(F) OCR and ECARmeasurements of control and ERRg knockdown retroviral reprogrammingMEF cells demonstrate that ERRg is required for the early OXPHOS
burst in mouse cells (n = 6, error bars show SD).
(G) Rotenone treatment, which inhibits the OXPHOS burst, results in significant reduction of retroviral reprogramming efficiency in IMR90, suggesting that the
metabolic switch is essential (n = 3, *p < 0.05, error bars show SD).switch in the heterogeneous cell populations present in the early
stages of reprogramming, we hypothesized that the subpopula-
tion of bona fide iPSC progenitors might be enriched for the
ERR-mediated hyperenergetic burst. Analysis of cell surface
markers differentially expressed during MEF reprogramming re-
vealed that early clusters of reprogramming cells lack the550 Cell Stem Cell 16, 547–555, May 7, 2015 ª2015 Elsevier Inc.expression of stem cell antigen 1 (Sca1) and cluster of differen-
tiation gene 34 (CD34) expression (Figures 3A and 3B). Upon
OSKM induction, CD34 expression is promptly upregulated, re-
sulting in three distinct cell subpopulations in early reprogram-
ming cells: Sca1CD34 double negative (DN), Sca1+CD34+
double positive (DP), and Sca1+CD34 single positive (SP)
AC
G
D E F
B
Figure 3. ERRg Enriched Subpopulation in Early Reprogramming Represent Bona Fide Reprogramming Cells with Significantly Enhanced
Reprogramming Efficiency
(A) Sca1 and CD34 label bona fide reprogramming cells. Retroviral OSKM-infectedMEFs stained for Sca1 (green) and CD34 (red) expression and phase-contrast
image (right). Sca1CD34 DN cells are demarcated by white dashed lines from phase-contrast images.
(B) Representative phase contrast images of Sca1CD34 cells during retroviral reprogramming. Arrowheads indicate a representative DN colony.
(C and D) qPCR demonstrating that ERRg and PGC-1b are enriched in the DN population (n = 3, error bars show SEM, *p < 0.01).
(E and F) FACS-isolated DN population exhibits higher ECAR (E) and OCR (F) than DP or SP population (n = 4, *p < 0.05, error bars show SD).
(G) DN cells demonstrate significantly higher reprogramming efficiency (n = 7, *p < 0.05, **p < 0.01).(Figure S3A). Correlating with immunofluorescence staining (Fig-
ure 3A), only a minor fraction (3%–5%) of early reprogramming
cells are Sca1CD34 (Figure S3A). Strikingly, ERRg and
PGC-1b expression were10- and7-fold higher, respectively,
in the early reprogramming DN cells compared with DP or SP
cells, as determined by qPCR analysis (Figures 3C and 3D).
Importantly, these early reprogramming DN cells exhibited
significantly elevated ECAR and OCR compared with DP or SP
populations (Figures 3E and 3F), consistent with Sca1CD34
labeling a subpopulation of hyperenergetic cells. Notably,
Sca1CD34 cells present in non-infected MEFs do not show
elevated reprogramming efficiency (Figure S3B). To test our
hypothesis that this hyperenergetic state is required for reprog-
ramming, we compared the number of iPS colonies generated
from isolated DN, SP, and DP cells. While DN cells compriseonly 5% of the infected cells, they were approximately 50-
fold more efficient at generating iPSCs than the DP or SP popu-
lations, based on Nanog staining (Figure 3G; 35.5% [DN] versus
0.6% [DP] or 0.8% [SP]). The iPSCs derived from the DN popu-
lation showed ESC-likemorphology and expressed high levels of
AP activity aswell as pluripotencymarkers (Figures S3C–S3E). In
addition, embryoid body differentiation of the DN-derived iPSCs
produced markers from each of the three germ layers (Fig-
ure S3F). Moreover, iPSCs generated from DN cells contributed
to the formation of chimeric mice with subsequent crosses
demonstrating germline competency (Figures S3G and S3H).
Collectively, these data indicate that the hyperenergetic cells
identified in early reprogramming represented by the DN popula-
tion are bona fide reprogramming precursors that generate
iPSCs at high efficiency.Cell Stem Cell 16, 547–555, May 7, 2015 ª2015 Elsevier Inc. 551
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Figure 4. Transcriptome Analysis Reveals that ERRs Orchestrate the Upregulation of a Panel of OXPHOS-Related Genes and Promote the
Metabolic Switch during Early Reprogramming
(A and B) RNA-seq analysis reveals that the genome-wide expression pattern of various cell types can be grouped into pluripotent stem cells, MEFs, and in-
termediate retroviral reprogramming cells, demonstrated by distance matrix (A) and clustering analysis (B).
(C and D) The RNA-seq patterns of a subset of key pluripotency markers (C) and cell-cycle genes (D) reveal similarity between DN cells and ESCs, suggesting that
the DN population represent bona fide early reprogramming cells which are in the process of adopting induced pluripotency.
(E) Expression heat map from RNA-seq data show that DN cells have a unique pattern in metabolic genes that represents a hyperenergetic state.
(F) Heat map of gene expression from microarray in IMR90 cells after ERRa depletion, showing that a significant portion of the OXPHOS program is directly
influenced by ERRa in human fibroblast reprogramming.
(G) Schematic representation of the role of ERRs and PGC1a/b in inducing the early OXPHOS burst and transition to induced pluripotency. The OXPHOS burst is
required for somatic cell reprogramming and transient activation of ERRs, and their co-factors are epistatic to the roadblock of p53/p21-induced senescence in
reprogramming.Reprogramming Cells Undergo an ERR-Mediated
OXPHOS Burst
To better understand themolecular underpinnings of cell reprog-
ramming and cell fate determination, we compared the complete
transcriptomes, determined by RNA-seq, of somatic fibroblasts
(non-infectedMEFs,mock-infectedMEFs at day 5), intermediate
reprogramming cell populations (DN, DP, SP, unsorted day 5552 Cell Stem Cell 16, 547–555, May 7, 2015 ª2015 Elsevier Inc.cells), and pluripotent stem cells (iPSCs generated from the DN
population and mESCs). Not unexpectedly, distance matrix
and clustering analyses grouped the cell types into the above
three categories (Figures 4A and 4B). The clear separation of
the DN population from the pluripotent stem cells indicates
that these transitional cells have yet to adopt a durable pluripo-
tency fate. Furthermore, the more subtle separation of the DN
population from the other intermediate reprogramming cells in
the cluster analysis suggests that they should express a unique
gene signature associated with enhanced reprogramming effi-
ciency (Figure 4B). Indeed, the expression of selected pluripo-
tency markers and key cell-cycle genes in the DN population
more closely resembles that observed in ESCs and iPSCs than
found in the DP and SP populations (Figures 4C and 4D). How-
ever, a majority of other stem cell markers, including ERRb and
Nanog, are not enriched in the DN population (data not shown).
Thus, the DN cell population is in a definable transcriptional and
metabolic state that appears to facilitate efficient progression
toward pluripotency.
Pivotal pathways controlling the enhanced reprogramming
efficiency of DN cells were identified by comparing transcrip-
tomes between DN, DP, or SP populations. Interestingly,
KEGG pathway analysis of the differentially regulated genes
identified OXPHOS as the most significantly altered pathway in
DN cells (Figures S4A and S4B). Furthermore, a comparison of
the expression levels of genes involved in cellular energy meta-
bolism revealed that the majority are upregulated in the DN
population (Figure 4E), consistent with the DN population
comprising the most hyperenergetic cells. This supports the
idea that a key feature of bona fide reprogramming is directing
progenitors to enter a hyperenergetic state.
Finally, to determine whether a causal association exists be-
tween the ERR surge and the increased expression of energy
metabolism genes, the transcriptional consequences of ERRa
knockdown in reprogramming IMR90s were examined. The
expression of a large number (1061) of metabolic genes was
significantly affected by ERRa depletion (Figure S4C). In partic-
ular, dramatic decreases in the expression of regulators of
cellular energy homeostasis, including NADH dehydrogenases
(NDUF), succinate dehydrogenases (SDH), mitochondrial respi-
ratory chains (COX), ATPase, and ATP synthases in mitochon-
dria were seen (Figure 4F). The fact that ERRa depletion
influences the expression of a plethora of mitochondrial genes,
including a variety of genes in complex I–V, and the TCA cycle
(Figure 4F), further supports the conclusion that transient
ERRa/g expression induces an equally transient OXPHOS burst,
facilitating reprogramming and enabling the transition from the
somatic to pluripotent state (Figure 4G).
DISCUSSION
Recent single-cell expression analyses revealed a requirement
for early expression of ERRb (Buganim et al., 2012), previously
demonstrated by Feng et al. (2009) to be a ‘‘Myc substitute.’’
In this model, Sox2 and ERRb mutually enhance each other’s
expression and initiate the reprogramming process, presumably
in all transfected cells (Buganim et al., 2012). Here we reveal a
downstream requirement for other ERR family members, ERRa
and ERRg, together with their co-activators PGC-1a/b, that
define a distinct subpopulation of cells with dramatically
enhanced efficiency for iPSC generation. A transient surge in
ERRa/g and PGC1a/b expression during reprogramming in-
duces an early metabolic switch epitomized by a transient
OXPHOS burst and sustained enhanced glycolysis. These find-
ings complement a recent study demonstrating stage-specific
roles for HIF1a and HIF2a in the early increase in glycolytic meta-bolism (Mathieu et al., 2014). The surprising functional diver-
gence between ERRa/g and ERRb adds a new dimension to
themodel for reprogramming, in which transient ERRa/g expres-
sion is required to drive an early hyperenergetic metabolic state
characterized by increased OXPHOS and glycolysis, whereas
ERRb is required for establishing induced pluripotency at later
reprogramming stages (Chen et al., 2008; Martello et al., 2012;
Zhang et al., 2008). The fact that metabolic reprogramming is
a prerequisite of induced pluripotency reveals the functional
relevance of a unique metabolic state to achieving cell plasticity.
Furthermore, via cell sorting of Sca1/CD34 DN cells, we demon-
strate that ERRg and PGC-1b are early markers of a newly
defined subgroup of reprogramming progenitors. In summary,
these studies characterize a previously unrecognized, ERR/
PGC-1-dependent metabolic switch prior to establishment
of induced pluripotency in both human and mouse cells
(Figure 4G).
EXPERIMENTAL PROCEDURES
MEFs were isolated from embryonic day (E) 13.5 embryos obtained from WT
and ERRg-deficient mice (Alaynick et al., 2007). All animal protocols were
reviewed and approved by the Salk Institute of Animal Care and Use Commit-
tee (IACUC), and studies were conducted in compliance with institutional and
national guidelines. Retroviruses and lentiviruses were produced in HEK293T
cells and 12 to 14 days after infection MEFs were fixed for staining. Reprog-
ramming of MEFs and IMR90 cells were done as previously described (Kawa-
mura et al., 2009; Sugii et al., 2010; Takahashi et al., 2007; Wei et al., 2013; Yu
et al., 2007). Illumina BeadChip microarrays on OSKM-induced IMR90 cells in-
fected with shERRa or GFP were performed as previously described (Narkar
et al., 2011). RNA-seq libraries were prepared with TruSeq RNA Sample Prep-
aration Kit v2 (Illumina) and sequenced on an Illumina HiSeq 2000 using multi-
plexed bar coding and a 100-bp read length. Description of read analysis
methods are provided in the Supplemental Information. Bioenergetic assays
were performed on a Seahorse XF instrument to measure OXPHOS capacity.
OCR and ECAR values were normalized by measuring the cell number in each
well using Hoechst 33342 staining followed by quantification of fluorescence
at 355 excitation and 460 emission. Intracellular NAD+ and NADH levels
were measured by NAD+/NADH Assay Kit (Abcam) as per manufacturer’s in-
structions. Intracellular ATP was measured by ATP assay kit (Sigma-Aldrich)
according to manufacturer’s directions. shRNA constructs were purchased
from Openbiosystems. Lentiviral shRNA were produced in 293T cells and
polybrene (6 mg/ml) was used in transduction. For reprogramming experi-
ments, cells were transduced with lentiviral shRNA at day 0 of reprogramming.
Detailed methods can be found in the Supplemental Information.
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